Recent Articles

People who walk more or walk faster live longer, study finds

For sleep apnea, a dental device may be as effective as CPAP

Rosacea treatments: What works?

Carb cycling: What is it, and does it work?

Understanding orthorexia: Have your healthy eating goals gone too far?

Salmonella, E. coli, Cyclospora, and other germs that cause food poisoning: What you need to know

Melatonin or magnesium: Can either supplement help you sleep?

Naturally gluten-free foods

Shingrix shingles vaccine linked with lower heart disease risks

Harvard study: Healthier fats linked to longer life after prostate cancer diagnosis

Andrew Chan, MD, MPH

Contributor

Andrew T. Chan, MD, MPH is a Professor of Medicine at Harvard Medical School (HMS), Chief of the Clinical and Translational Epidemiology Unit, and the Program Director for gastroenterology training at Massachusetts General Hospital (MGH). As a clinical gastroenterologist, Dr. Chan specializes in familial gastrointestinal cancer syndromes and cancer prevention. Dr. Chan is a leading investigator in the epidemiology of colorectal cancer and other digestive diseases, with a focus on chemoprevention with aspirin and the interaction of diet with the gut microbiome. An elected fellow of the American Society of Clinical Investigation, he currently supported by NCI, NIDDK, and the Crohn’s and Colitis Foundation for his research. He has published over 400 papers in the field of colorectal cancer and other chronic digestive diseases in leading journals, including the New England Journal of Medicine, Journal of the American Medical Association, Lancet, Science Translational Medicine, Gastroenterology and Gut. Dr Chan is a section editor for Gastroenterology, serves on the editorial board of Cancer Prevention Research and Cancer Epidemiology Biomarkers and Prevention, and is vice-chair of the Gastrointestinal Oncology Section of the AGA.